- Home
- CXW vs HRMY Comparison
CXW vs HRMY Comparison
Compare CXW & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CXW | HRMY |
|---|---|---|
| Founded | 1983 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CXW | HRMY |
|---|---|---|
| Price | $18.99 | $39.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $34.00 | ★ $51.33 |
| AVG Volume (30 Days) | ★ 1.0M | 789.9K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 49.55 | ★ 50.44 |
| EPS | 1.00 | ★ 3.17 |
| Revenue | ★ $2,086,522,000.00 | $825,944,000.00 |
| Revenue This Year | $12.51 | $23.11 |
| Revenue Next Year | $14.77 | $16.15 |
| P/E Ratio | $18.82 | ★ $12.79 |
| Revenue Growth | 5.72 | ★ 21.13 |
| 52 Week Low | $15.95 | $25.52 |
| 52 Week High | $23.85 | $40.93 |
Technical Indicators
Market Signals| Indicator | CXW | HRMY |
|---|---|---|
| Relative Strength Index (RSI) | 62.40 | 67.08 |
| Support Level | $18.48 | $38.12 |
| Resistance Level | $18.94 | $40.00 |
| Average True Range (ATR) | 0.38 | 1.26 |
| MACD | 0.15 | 0.13 |
| Stochastic Oscillator | 88.37 | 68.68 |
Price Performance
Historical ComparisonAbout CXW CoreCivic Inc.
CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.